Abstract

LEON-ESPITIA, Marco A. de. The third side of the coin in the management of heart failure. Rev. Colomb. Cardiol. [online]. 2022, vol.29, n.3, pp.334-341.  Epub Sep 01, 2022. ISSN 0120-5633.  https://doi.org/10.24875/rccar.21000024.

In the last decades the management of heart failure has seen significant advance as never before in the history of cardiology, raising the life expectancy of patients with heart failure to levels close to those of healthy individuals. For such a task, multiple pharmacological alternatives have been employed: angiotensin converting enzyme inhibitors (ACEI), angiotensin receptor antagonists (ARB), mineralocorticoid receptor antagonists, I-F channel antagonists, neprilysin inhibitors, beta blockers, associated to the development of interventionist cardiology and cardiac surgery at coronary level, valvular level, cardiac remodeling, and devices for stimulation, assistance, resynchronization and myocardial cardioversion. However, there is an important stage in the management of heart failure that occasionally, due to varied circumstances, is set aside or put off as a front-line therapy accompanying the ones already mentioned. This article attempts to describe the importance that said therapies have in light of current evidence, which we have called: the third side of the coin in the management of heart failure.

Keywords : Heart failure; Integral treatment; Reduced ejection fraction; Preserved ejection fraction; Prognosis.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )